Author

Arianna Corsini

Universit

Biography

Dr. Arianna Corsini belongs to Department of Dermatology, Out-patient Service, Livorno, Italy. His research interest includes Dermatology, Venerology, Autoimmune bullous disease, Epidermolysis, Skin.
Title
Cited by
Year
Fibroblast growth factors (FGFs) in cancer: FGF traps as a new therapeutic approach
M Presta, P Chiodelli, A Giacomini, M Rusnati, R RoncaPharmacology & therapeutics 179, 171-187, 2017201
150
2017
Long-pentraxin 3 derivative as a small-molecule FGF trap for cancer therapy
R Ronca, A Giacomini, E Di Salle, D Coltrini, K Pagano, L Ragona, ...Cancer cell 28 (2), 225-239, 2015201
105
2015
Blocking the FGF/FGFR system as a⿿ two-compartment⿿ antiangiogenic/antitumor approach in cancer therapy
A Giacomini, P Chiodelli, S Matarazzo, M Rusnati, M Presta, R RoncaPharmacological research 107, 172-1, 2016201
85
2016
The potential of fibroblast growth factor/fibroblast growth factor receptor signaling as a therapeutic target in tumor angiogenesis
R Ronca, A Giacomini, M Rusnati, M PrestaExpert opinion on therapeutic targets 19 (10), 1361-1377, 2015201
85
2015
Long pentraxin 3: A novel multifaceted player in cancer
A Giacomini, GC Ghedini, M Presta, R RoncaBiochimica et Biophysica Acta (BBA)-Reviews on Cancer 1869 (1), 53-63, 2018201
76
2018
Long pentraxin-3 inhibits epithelial–mesenchymal transition in melanoma cells
R Ronca, E Di Salle, A Giacomini, D Leali, P Alessi, D Coltrini, C Ravelli, ...Molecular cancer therapeutics 12 (12), 2760-2771, 2013201
74
2013
Long pentraxin‐3 as an epithelial–stromal fibroblast growth factor‐targeting inhibitor in prostate cancer
R Ronca, P Alessi, D Coltrini, E Di Salle, A Giacomini, D Leali, M Corsini, ...The Journal of pathology 230 (2), 228-238, 2013201
70
2013
Brain angioarchitecture and intussusceptive microvascular growth in a murine model of Krabbe disease
A Giacomini, M Ackermann, M Belleri, D Coltrini, B Nico, D Ribatti, ...Angiogenesis 18, 499-510, 2015201
42
2015
Human CD34+ cells engineered to express membrane-bound tumor necrosis factor–related apoptosis-inducing ligand target both tumor cells and tumor vasculature
C Lavazza, C Carlo-Stella, A Giacomini, L Cleris, M Righi, D Sia, ...Blood, The Journal of the American Society of Hematology 115 (11), 2231-2240, 2010201
41
2010
Sorafenib inhibits lymphoma xenografts by targeting MAPK/ERK and AKT pathways in tumor and vascular cells
C Carlo-Stella, SL Locatelli, A Giacomini, L Cleris, E Saba, M Righi, ...PloS one 8 (4), e61603, 2013201
39
2013
Perifosine and sorafenib combination induces mitochondrial cell death and antitumor effects in NOD/SCID mice with Hodgkin lymphoma cell line xenografts
SL Locatelli, A Giacomini, A Guidetti, L Cleris, R Mortarini, A Anichini, ...Leukemia 27 (8), 1677-1687, 2013201
37
2013
Inhibition of angiogenesis by β-galactosylceramidase deficiency in globoid cell leukodystrophy
M Belleri, R Ronca, D Coltrini, B Nico, D Ribatti, PL Poliani, A Giacomini, ...Brain 1 (9), 2859-2875, 2013201
36
2013
Antiangiogenic effects of N6‐isopentenyladenosine, an endogenous isoprenoid end product, mediated by AMPK activation
S Pisanti, P Picardi, E Ciaglia, L Margarucci, R Ronca, A Giacomini, ...The FASEB Journal 28 (3), 1132-1144, 2014201
35
2014
A long pentraxin-3-derived pentapeptide for the therapy of FGF8b-driven steroid hormone-regulated cancers
A Giacomini, S Matarazzo, K Pagano, L Ragona, S Rezzola, M Corsini, ...Oncotarget 6 (15), 13790, 2015201
31
2015
Synthesis, structural elucidation, and biological evaluation of NSC12, an orally available fibroblast growth factor (FGF) ligand trap for the treatment of FGF-dependent lung tumors
R Castelli, A Giacomini, M Anselmi, N Bozza, F Vacondio, S Rivara, ...Journal of Medicinal Chemistry 59 (10), 4651-4663, 2016201
28
2016
sTRAIL coupled to liposomes improves its pharmacokinetic profile and overcomes neuroblastoma tumour resistance in combination with Bortezomib
M Loi, P Becherini, L Emionite, A Giacomini, I Cossu, E Destefanis, ...Journal of Controlled Release 192, 157-166, 2014201
26
2014
Myeloablative doses of yttrium‐90‐ibritumomab tiuxetan and the risk of secondary myelodysplasia/acute myelogenous leukemia
A Guidetti, C Carlo‐Stella, M Ruella, R Miceli, L Devizzi, SL Locatelli, ...Cancer 117 (22), 5074-5084, 2011201
23
2011
U94 of human herpesvirus 6 down-modulates Src, promotes a partial mesenchymal-to-epithelial transition and inhibits tumor cell growth, invasion and metastasis
F Caccuri, R Ronca, AS Laimbacher, A Berenzi, N Steimberg, ...Oncotarget 8 (27), 44533, 2017201
15
2017
A computational approach to compare microvessel distributions in tumors following antiangiogenic treatments
M Righi, A Giacomini, C Lavazza, D Sia, C Carlo-Stella, AM GianniLaboratory investigation 89 (9), 1063-1070, 2009200
13
2009
D Quantification of Tumor Vasculature in Lymphoma Xenografts in NOD/SCID Mice Allows to Detect Differences among Vascular-Targeted Therapies
M Righi, A Giacomini, L Cleris, C Carlo-StellaPloS one 8 (3), e561, 2013201
9
2013

Referred From: https://scholar.google.com/citations?user=DgxeDOUAAAAJ&hl=en

Cited by
Citations 1029
h-index 17
i10-index 19
Recommended Journals
Open Access Journals